Nasal breathing and continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea (OSA)
- PMID: 12861488
- DOI: 10.1007/s11325-003-0087-7
Nasal breathing and continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea (OSA)
Abstract
Although nasal continuous positive airway pressure (nCPAP) treatment is the most efficient therapy for obstructive sleep apnea (OSA), compliance with therapy is poor because of several side effects. Among these adverse effects some are related to the reactions of the nose to nCPAP which are briefly described. In a long-term survey of 109 OSA patients, 80.6% continued nCPAP for at least 3 years until the last follow-up. Follow-up ranged between 0.8 and 109 months with a mean time of 43 (SD +/- 24.7) months. Among all patients treated with nCPAP, only 46.6% met our criteria for long-term compliance, defined as a mean use of the CPAP machine for at least 5 hours per night. Within the objective measures such as age, body mass index, neck circumference, nasal airflow, apnea-hypopnea index, minimal oxygen saturation, and level of nCPAP pressure, no predictive factor for daily use of nCPAP could be found. However, pretherapeutic daytime somnolence (measured by visual analogue scale and Epworth Sleepiness Scale) and its improvement obtained from the therapy showed a significant effect on the daily use of the CPAP machine.
Similar articles
-
[Therapy with nasal CPAP (continuous positive airway pressure) in patients with obstructive sleep apnea syndrome (OSAS). I: Long-term acceptance of nasal CPAP].Laryngorhinootologie. 1997 Sep;76(9):550-3. doi: 10.1055/s-2007-997477. Laryngorhinootologie. 1997. PMID: 9417184 German.
-
Acoustic rhinometry predicts tolerance of nasal continuous positive airway pressure: a pilot study.Am J Rhinol. 2006 Mar-Apr;20(2):133-7. Am J Rhinol. 2006. PMID: 16686374
-
Nasal continuous positive airway pressure treatment reduces systemic oxidative stress in patients with severe obstructive sleep apnea syndrome.Sleep Med. 2009 Jan;10(1):87-94. doi: 10.1016/j.sleep.2007.10.011. Epub 2008 Feb 20. Sleep Med. 2009. PMID: 18077211 Clinical Trial.
-
The Nose and Nasal Breathing in Sleep Apnea.Otolaryngol Clin North Am. 2020 Jun;53(3):385-395. doi: 10.1016/j.otc.2020.02.002. Epub 2020 Mar 17. Otolaryngol Clin North Am. 2020. PMID: 32192710 Review.
-
Nasal Obstruction Considerations in Sleep Apnea.Otolaryngol Clin North Am. 2018 Oct;51(5):1003-1009. doi: 10.1016/j.otc.2018.05.012. Epub 2018 Jun 20. Otolaryngol Clin North Am. 2018. PMID: 29934201 Review.
Cited by
-
Initial adherence to autotitrating positive airway pressure therapy: influence of upper airway narrowing.Clin Exp Otorhinolaryngol. 2009 Dec;2(4):181-5. doi: 10.3342/ceo.2009.2.4.181. Epub 2009 Dec 31. Clin Exp Otorhinolaryngol. 2009. PMID: 20072692 Free PMC article.
-
The effect of nasal surgery on continuous positive airway pressure device use and therapeutic treatment pressures: a systematic review and meta-analysis.Sleep. 2015 Feb 1;38(2):279-86. doi: 10.5665/sleep.4414. Sleep. 2015. PMID: 25325439 Free PMC article.
-
The effects of heated humidifier in continuous positive airway pressure titration.Sleep Breath. 2013 Mar;17(1):133-8. doi: 10.1007/s11325-012-0661-y. Epub 2012 Feb 4. Sleep Breath. 2013. PMID: 22311554 Free PMC article. Clinical Trial.
-
Obstructive Sleep Apnea and Stroke: Determining the Mechanisms Behind their Association and Treatment Options.Transl Stroke Res. 2024 Apr;15(2):239-332. doi: 10.1007/s12975-023-01123-x. Epub 2023 Mar 16. Transl Stroke Res. 2024. PMID: 36922470 Review.
-
Rhinitis and sleep apnea.Curr Allergy Asthma Rep. 2004 May;4(3):193-9. doi: 10.1007/s11882-004-0026-0. Curr Allergy Asthma Rep. 2004. PMID: 15056401 Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous